Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Vaccine stocks moved higher early Monday following a CDC report that the U.S. was seeing a significant uptick in seasonal influenza, COVID-19 and RSV infections. Read more here.

Value stocks have lagged well behind growth stocks in recent years. D.R. Horton (NYSE: DHI) is the largest homebuilder in the ...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

Shares of vaccine-related stocks are trading higher following the latest bird flu developments, as well as a rise in respiratory illness. Novavax has a bird flu vaccine in clinical trials in addition ...

Phibro Animal Health's PAHC diversified product portfolio and wide presence in key growth areas bolster our confidence in the ...

ModeX Therapeutics, an Opko Health (OPK) company, announces dosing of the first participant in the Phase I study of an -Barr Virus, EBV, ...

Wuxi Biologics (WXXWY) plans to sell its Irish vaccine facility to Merck (MRK) for around $500M ahead of potential U.S. legislation that would ...

The equity is pulling back slightly today, though it remains well above its Nov. 15 dip to $24.48 -- its lowest mark since ...

Vaccine stocks received a major and sudden boost on January 7, 2025. Here's why these companies are experiencing tailwinds in ...